OncoSenX
OncoSenX develops targeted cancer therapies that use a proteo-lipid vehicle to deliver plasmid DNA, inducing apoptosis in cancer cells based on their transcriptional activity. Its approach aims to precisely target solid tumors while minimizing side effects and avoiding harm to healthy cells.
Facts
- HQ
- Seattle, Washington
- Sectors
- Biotechnology, Therapeutics, Oncology
- Stage
- Seed
- Members see funding amounts. .
Is this your organization? Claim it
Members see OncoSenX's funding rounds, amounts and investors.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Eric Garcia Executive, Chief Operating Officer
-
Matthew Scholz Executive, Chief Executive Officer
-
Stephen Hilbert Executive, Chief Business Officer